Stephan Busque
Academic Appointments
- Professor - Med Center Line, Surgery - Multi-Organ Transplantation
Key Documents
Contact Information
-
Clinical Offices
Transplant Surgery 750 Welch Rd Ste 319 MC 5731 Palo Alto, CA 94304 Tel Work (650) 498-6189 Fax (650) 498-5690Kidney Transplant Clinic 300 Pasteur Dr A160 MC 5309 Stanford, CA 94305 Tel Work (650) 723-6961 Fax (650) 725-8418Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information EmailNot for medical emergencies or patient use
Professional Overview
Clinical Focus
- General Surgery
- Kidney and Pancreas Transplantation
- Liver Transplantation
Administrative Appointments
- Director Adult Kidney and Pancreas Transplant Program, Stanford University School of Medicine (2001 - present)
Professional Education
| Residency: | University of Montreal, Canada (1991) |
| Medical Education: | University of Montreal, Canada (1986) |
| Fellowship: | California Pacific Medical Center CA (1995) |
| Internship: | University of Montreal, Canada (1987) |
| Board Certification: | General Surgery, American Board of Surgery (1996) |
| Board Cerification: | American Board of Surgery, General Surgery (1996) |
Scientific Focus
Current Research Interests
My research interest is centered on the improvement of clinical immunosuppression. This involves the evaluation of new immunosuppressive drugs that are potentially more efficacious and/or less toxic or better monitoring of the effect of these drugs. We are participating in the drug development process from phase1 to phase 3 studies. I participate to trial design and data analysis of some of these trials. The ultimate goal is to achieve tolerance, a state that would obviate the need for any drugs. I am a clinical investigator in a multidisciplinary trial aimed at inducing tolerance after kidney transplantation. My other interests include the development and study of efficacy of strategies to desensitized organ transplant recipients and expending our capabilities to tailor the immunosuppression needs of specific patients through new immune-monitoring tests. Ultimately these research projects are aimed at improving the outcomes of organ transplant recipients.
Publications
- Desensitization combined with paired exchange leads to successful transplantation in highly sensitized kidney transplant recipients: strategy and report of five cases. Transplant Proc. 2013 Jan-Feb; (1): 82-7
- A preconditioning regimen with a PKCĪµ activator improves islet graft function in a mouse transplant model. Cell Transplant. 2013
- Evaluating deceased donor registries: identifying predictive factors of donor designation. Am Surg. 2013; (3): 235-41
- Incidental kidney stones: a single center experience with kidney donor selection. Clin Transplant. 2012 Jul-Aug; (4): 558-63
- Chain transplantation: initial experience of a large multicenter program. Am J Transplant. 2012; (9): 2429-36
- Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year. Am J Transplant. 2012; (9): 2446-56
Help
Trial Administration